Relatively few studies of hypertension have been carried out in Mexican-Americans, a population characterized by high rates of obesity and non-insulin-dependent diabetes mellitus. We therefore compared the prevalence of hypertension according to four different definitions in 3,297 Mexican-Americans and in 1,873 non-Hispanic whites from the San Antonio Heart Study, a population-based study of cardiovascular disease and diabetes. By all four definitions, the crude prevalence of hypertension in both sexes was lower in Mexican-Americans than in non-Hispanic whites, although only two of the eight pairwise comparisons were statistically significant However, after adjusting for the potentially confounding effects of age, body mass index, and non-insulin-dependent diabetes mellitus, Mexican-Americans did have a statistically significant lower prevalence of both systolic and diastolic hypertension than did non-Hispanic whites in both sexes (odds ratios ranging from 0.66 to 0.71 depending on the definition of hypertension). The cause of this lower prevalence is unknown, but study of this ethnic group with elevated levels of risk factors for hypertension (obesity, hyperinsulinemia, and diabetes) may provide additional insights into the etiology of hypertension. {Hypertension 1990;16:225-232)
A lthough many studies have established the high / \ prevalence of hypertension in blacks in the A. \ . United States, 1 -3 relatively few surveys have been performed in Mexican-Americans. 4 - 8 Paradoxically, several of these studies have suggested that Mexican-Americans have a lower prevalence of hypertension than non-Hispanic whites (especially among women), although none of these studies are definitive. However, even a similar prevalence would be surprising because, compared with non-Hispanic whites, Mexican-Americans are both more obese 7910 and have a higher prevalence of non-insulindependent diabetes mellitus (NIDDM), 7 -9 -11 - 13 both of which conditions are well-recognized risk factors for hypertension. 1415 Limitations of earlier studies include small sample size, which might account for the lack of statistical significance of the ethnic differences, 4 ' 6 lack of a suitable control group, 5 
"
7 or failure to control for potential confounding vari-ables. 5 - 8 We have previously reported findings on hypertension prevalence from phase I of the San Antonio Heart Study (SAHS) (1979) (1980) (1981) (1982) . 4 We now present findings from both phase I (n=2,217) and phase II (1984) (1985) (1986) (1987) (1988) {n=2,953) of this study, thereby increasing our statistical power to detect ethnic differences in hypertension prevalence. Also in the present report, we examine these ethnic differences after controlling for the potentially confounding effects of age, obesity, and NIDDM.
Methods
The SAHS is a population-based study of diabetes and cardiovascular disease in Mexican-American and non-Hispanic white men and women 25-64 years of age. Detailed descriptions of the study design, sampling procedures, response rates, and field procedures have appeared elsewhere. 16 Recruitment of subjects into the SAHS occurred in two phases: the first encompassed the period from October 1979 to November 1982 and the second the period from October 1984 to October 1988. Both phases consisted of independent random samples conducted in different groups of census tracts. The data from both phases are pooled in the analyses presented in this paper. The study was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio, and all subjects gave informed consent.
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Hypertension Vol 16, No 3, September 1990 Ethnicity was denned on the basis of a previously published algorithm that considered parental surnames and birthplaces, stated ethnicity of grandparents, and the participant's preferred ethnic identity when a distinct national origin was indicated. 17 Persons who were identified as belonging to an ethnic group other than Mexican-American or nonHispanic white were excluded from the present analyses. Socioeconomic status was determined according to years of education, and subjects were classified into one of three categories: 1) less than high school, 2) high school, and 3) some college or beyond.
Anthropometric measurements (height and weight) were made with the participant wearing an examination gown after having removed his or her shoes and upper garments. Body mass index was calculated as weight (in kilograms) divided by height (in meters) squared. The systolic (first phase) and diastolic (fifth phase) blood pressures were measured, using a random zero sphygmomanometer (Hawksley-Gelman, London), to the nearest even digit on the right arm of the seated participant after at least a 5-minute rest period. Three readings were recorded for each individual, and the subject's blood pressure was defined as the average of the second and third reading. 3 Included under each definition are treated subjects whose blood pressures are "controlled" (i.e., below the stated cut point).
Blood specimens were obtained after a 12-hour fast for plasma glucose and serum lipid and lipoprotein determinations. After the fasting specimen had been obtained, a 75 g glucose equivalent load (Koladex or Orangedex, Custom Laboratories, Baltimore, Md.) was administered, and blood samples were obtained 1 and 2 hours later for post-glucose load plasma glucose determinations. Plasma glucose concentrations were measured with an Abbott Bichromatic Analyzer (Abbott Laboratories, South Pasadena, Calif.). Diabetes was diagnosed according to the plasma glucose criteria of the National Diabetes Data Group (NDDG). 19 Individuals who did not meet the NDDG criteria but who gave a history of diabetes and who were currently under treatment with either oral antidiabetic agents or insulin were also considered to have diabetes. Diabetic subjects who were not taking insulin were considered to have NIDDM. Subjects taking insulin but whose age at onset was greater than 40 years and who had a body mass index 30 kg/m 2 or greater were also considered to have NIDDM. Other diabetic subjects were considered to have insulin-dependent diabetes mellitus (n = 16) or to be unclassifiable (n=17) and are excluded from analyses involving diabetes. Differences in mean age and body mass index between ethnic groups were evaluated using two-way analysis of variance with ethnicity and sex as grouping variables (Table 1 ). Summary odds ratios (OR) for ethnicity, adjusted for age, body mass index, NIDDM, or educational attainment were calculated by the Mantel Haenszel technique (Tables 2-4, 8) . The effect of ethnicity on hypertension prevalence was also evaluated using multivariate models including a log linear model (Table 5 ) and a logistic regression model (Table 6 ). All analyses were performed using the SYSTAT statistical software.
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Results
The crude prevalence of hypertension according to each of the four definitions is presented in Table 1 . Using the first three definitions, hypertension prevalence was lower in Mexican-Americans than in nonHispanic whites in both sexes, although this deficit was statistically significant in only two of the six comparisons. There was little difference in the prevalence of mild hypertension between the two ethnic groups. Compared with non-Hispanic whites, Mexican-American subjects were younger, more obese, and had a higher prevalence of NIDDM than non-Hispanic white subjects, suggesting that confounding could have obscured a larger difference in hypertension prevalence between the two ethnic groups. Among hypertensive men (definition 1), Mexican-Americans were less likely to b&'on antihypertensive therapy than were non-Hispanic whites (110/139 or 79.1% versus 94/102 or 92.2%, respectively; /J<0.01). Among hypertensive women, there was no ethnic difference in the percent of hypertensive subjects on therapy (169/181 or 93.4% for Mexican-Americans versus 124/128 or 96.9% for nonHispanic whites). Tables 2-4 show the prevalence of diastolic hypertension according to ethnicity, age, body mass index, and prevalence of NIDDM. (The results using the other three definitions of hypertension were similar to those using the diastolic definition and thus are not presented.) Table 2 indicates that for both sexes the age-adjusted prevalence of hypertension was lower in Mexican-Americans than in non-Hispanic whites (age-adjusted OR=0.87 and 0.85 in men and women, respectively), although these differences were not statistically significant. Table 3 indicates that, within the strata of body mass index, MexicanAmericans had a statistically significant lower prevalence of hypertension in both men (body mass indexadjusted OR = 0.72, 95% confidence interval [CI]=0.54-0.95) and women (body mass indexadjusted OR=0.52, 95% CI=0.40-0.67). Table 4 indicates that Mexican-American men and women with NIDDM also have significantly lower prevalences of hypertension than non-Hispanic white men and women with NIDDM. Similarly, nondiabetic Mexican-American men and women have significantly lower prevalences of hypertension than nondiabetic non-Hispanic whites. Tables 2-4 also demonstrate that age, body mass index, and presence of NIDDM are all significantly positively related to hypertension prevalence (/><0.001). Tests for homogeneity of effects of each risk factor in the two ethnic groups on the prevalence of hypertension were performed, and in no case was there evidence for nonhomogeneous effects (p values all greater than 0.30).
A five-way, cross-classified table showing the effects of age, sex, body mass index, and ethnicity on diastolic hypertension is presented in Table 5 . In 18 of the 24 strata, Mexican-Americans had a lower prevalence of hypertension than did non-Hispanic whites, whereas in five strata they had a higher prevalence. There were no hypertensive individuals in one stratum. Furthermore, in the older age categories (45-64 years), which contain 78% (427 of 544) of the hypertensive subjects, Mexican-Americans had a lower prevalence of hypertension than nonHispanic whites in 11 of 12 strata. The effect of ethnicity was statistically significant (/?<0.001) in the log linear model after adjusting for age, sex, and body mass index, indicating that Mexican-Americans had a significantly lower prevalence of hypertension than did non-Hispanic whites.
The results of a multiple logistic regression model with diastolic hypertension as the dependent variable are presented in Table 6 . The independent variables included in the model were age, ethnicity, body mass index, and prevalence of NIDDM. Results in both sexes were very similar with all four independent variables significantly related to prevalence of hypertension. All first-order interactions involving ethnicity (i.e., ethnicityx age, ethnicityxbody mass index, and ethnicity x NIDDM) were also considered for inclusion in the regression model; none of these interactions were statistically significant, however, again supporting the concept that the effects of risk factors are similar in both ethnic groups.
Because the SAHS was conducted during two different time periods (phase 1,1979-1982 and phase II, 1984-1988), we considered whether the ethnic differences in hypertension prevalence might be related to a secular trend in hypertension prevalence. The prevalence of diastolic hypertension was higher in phase I than in phase II (men, OR (phase 1/ II)=1.32, 95% CI=0.99-1.76 and women, OR (phase I/II)=1.18, 95% CI=0.90,1.55), although this difference was not statistically significant. We therefore fit sex-specific multiple logistic regression models analogous to those presented in Table 6 but included a dummy variable for survey date (0=phase I; l=phase II). Ethnicity remained statistically associated with hypertension prevalence in both men (OR=0.72, 95% CI=0.54-0.97,p=0.03) and women (OR=0.61, 95% CI=0.46-0.81,p<0.001), and the magnitude of the OR was virtually unchanged in both sexes.
Additional multiple logistic regression models were examined using each of the three alternative definitions of hypertension as dependent variables ( Table 7) . The independent variables in each model were age, sex, body mass index, ethnicity, and NIDDM. The ethnic differences (Mexican-Americans/non-Hispanic whites) were very similar for the three more severe definitions of hypertension (ORs ranging from 0.66-0.71, /><0.001). For mild hypertension, however, MexicanAmericans had only a slightly lower prevalence of hypertension (OR=0.85), which was of only borderline statistical significance.
Because Mexican-Americans are predominantly of lower socioeconomic status 9 and because the prevalence of hypertension is inversely related to socioeconomic status, 21 we examined ethnic differences in Thirty-three subjects with insulin-dependent or unclassifiable diabetes are omitted from this table. They are, however, included in Tables 1-3. HBP, high blood pressure; NIDDM, non-insulin-dependent diabetes mellitus; CI, confidence interval. prevalence of hypertension was lower in MexicanAmericans than in non-Hispanic whites in five of six strata. We also repeated the multiple logistic regression analyses in Table 7 adjusting for education. The results were nearly identical except that the ethnic difference in hypertension prevalence was now significant for the mild hypertension definition as well (p=0.041).
Discussion
In San Antonio, hypertension occurs less frequently among Mexican-Americans than among nonHispanic whites. The deficit becomes even more evident (approximately 30%) when the confounding effects of obesity and diabetes are taken into account. Odds ratio was obtained by exponentiating the logistic regression coefficients. MA, Mexican-American; NHW, non-Hispanic white; BMI, body mass index; NIDDM, non-insulin-dependent diabetes mellitus; CI, confidence interval.
This finding is in striking contrast to the threefold excess of NIDDM observed in this ethnic group. 913 It is noteworthy that adjusting for obesity does not eliminate the excess of NIDDM, 22 whereas in the case of hypertension, such adjustment uncovers an actual deficit. Why Mexican-Americans should experience less hypertension is unclear; the variables of age, body mass index, and NIDDM appear to have similar effects on hypertension prevalence in both Mexican-Americans and non-Hispanic whites, suggesting that the lower prevalence in the former ethnic group is not due to an unusual resistance to these risk factors.
Although Odds ratio obtained by exponentiating the logistic regression coefficients. OR, odds ratio; MA, Mexican-American; NHW, non-Hispanic white; CI, confidence interval; DBP, diastolic blood pressure; meds, medication; SBP, systolic blood pressure. 30 Adjustment for these risk factors would thus be expected to exaggerate even further the discrepancy in hypertension prevalence between the two ethnic groups. (We did not consider insulin responses to oral glucose loading or upper body adiposity in this report because these measurements are available only in phase II of the SAHS.) We recently reported that hypertensive individuals are more hyperinsulinemic than nonhypertensive individuals in both diabetic and nondiabetic subjects of both ethnic groups in the SAHS. 31 It is also of interest that the finding of lower hypertension prevalence is not the result of lower socioeconomic status of Mexican-Americans. Although the effect of socioeconomic status is somewhat inconsistent in this report, adjustment for education actually increases the ethnic difference in hypertension prevalence and thus appears to act as a negative confounder.
One limitation of our study is that it is restricted to subjects residing in San Antonio. Outside of Texas, there are appreciable numbers of Mexican-Americans living in California, Arizona, New Mexico, and Colorado. Thus, confirmation of our results in other regions of the United States is needed. The lower prevalence of hypertension reported in the Hispanic HANES, 8 representing Mexican-Americans throughout the Southwest, however, suggests that this phenomenon is not restricted to San Antonio. It should also be noted that, because subjects with "treated" hypertension are included in each definition, ethnic differences in physicians' threshold to treat could lead to differences in hypertension prevalence.
Another possible explanation for the ethnic difference in hypertension prevalence is that borderline hypertensive non-Hispanic whites may be more likely to be placed on antihypertensive therapy than borderline Mexican-American hypertensive subjects. Because our definitions of hypertension included treated patients regardless of blood pressure level, such a bias would tend to inflate the non-Hispanic prevalence relative to the Hispanic prevalence. However, in women there was no ethnic difference in the proportion of hypertensive subjects under pharmacological treatment suggesting that such a bias does not occur, at least in women. Mexican-American hypertensive men, on the other hand, are somewhat less likely to be under treatment.
The finding of a decreased prevalence of hypertension in Mexican-Americans does not mean that hypertension is not an important public health problem in this ethnic group. In the first place, the deficit in crude rates (which are of the greatest public health relevance) are rather modest (Table 1) . Secondly, we have previously reported that hypertensive MexicanAmericans in a low income census tract of San Antonio were less likely to be under treatment with antihypertensive drugs than hypertensive nonHispanic whites. 4 Similarly, in the present larger study, male Mexican-American hypertensive subjects were less likely to be on pharmacological therapy. Finally, because Mexican-Americans have a high prevalence of diabetes 9 -13 and because hypertension is an important risk factor for diabetic complications, 32 hypertension undoubtedly has a major public health impact in this ethnic group even if it is somewhat less common than in non-Hispanic whites. Rather, the purpose of this report is to highlight a population with less hypertension than expected despite high levels of risk factors for this condition. This apparent contradiction may provide additional insights into the etiology of hypertension.
